iNOS-derived NO by MDSCs targets tumor infiltrating T cells and suppresses their functions by inhibiting T cell receptor signaling and Jak/STAT pathway activation and inducing T cell apoptosis. The gene discussed is NOS2; the disease is neoplasm.